Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings
Orgenesis-Theracell Joint Venture Secures €32M Grant From Greek Government